AVITA Medical, Inc. (RCEL) Free Cash Flow
AVITA Medical, Inc. (RCEL) free cash flow history and trends. Track FCF in Excel with MarketXLS.
Free Cash Flow Data
| Period | Free Cash Flow (USD) |
|---|---|
| 2019-06-30 | -$20.48M |
| 2020-06-30 | -$23.58M |
| 2021-06-30 | -$27.04M |
| 2022-12-31 | -$19.61M |
| 2023-12-31 | -$39.46M |
| 2024-12-31 | -$58.27M |
| 2025-12-31 | -$32.93M |
How RCEL compares with sector peers
| Symbol | Company | Free cash flow (latest fiscal year) |
|---|---|---|
| ATOS | Atossa Therapeutics Inc. | -$29.79M |
| VERU | Veru Inc. | -$30.04M |
| ENTA | Enanta Pharmaceuticals Inc. | -$32.17M |
| CRVS | Corvus Pharmaceuticals Inc. | -$32.97M |
| TENX | — | -$35.80M |
These are five companies in the same sector as RCEL with a comparable annual free cash flow. Each figure above is that company's most recent completed fiscal year, read from the same annual statements as the table on its own page, so the period end dates can differ between rows.
Get AVITA Medical, Inc. Data in Excel
Stream real-time stock prices and financials directly into your spreadsheets with MarketXLS.
Try: =hf_Free_Cash_Flow("RCEL", 2024)
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Volume |
| 2 | RCEL | $10.59 | +0.86% | 0.29M |
| 3 | ||||
| 4 | ||||
| 5 |